Watch the VPHi webinar on the AVICENNA ALLIANCE

On the 1st of March 2016, a team of both VPHi and Alliance members presented in details the goals and working plans of the new Avicenna Alliance for 2016
Watch the video

The Avicenna Alliance is a partnership with industry that will focus on promoting the in silico medicine market. With a 50-50 representation of industry and VPHi members, the Alliance will work toward addressing barriers to the uptake of VPH solutions. 

As major objective of 2016, the Alliance is planning the imminent launch of 3 important working groups, that will focus on these key areas:

Policy development

  1. Identification of challenges for the in silico market and research community and the development of corresponding policy solutions;
  2. Engagement with the European Parliament, Council and Commission on key dossiers and policy issues of importance to the Membership;
  3. Communication on the potential of in silico medicine for patients, healthcare professionals and industries.
Research
  1. Promotion of in silico medicine in Horizon 2020;
  2. Working towards the creation of a Public Private Partnership (PPP) on in silicomedicine;
  3. Creation of links between the VPHi Membership and Avicenna Industry Members
EU/USA/Asia
  1. Creation of links with Avicenna Alliance stakeholder counterparts in different Regulatory systems;
  2. Works towards a global harmonized framework for in silico medicine;

The participation to these working groups is open to all VPHi members, so in case you're interested to join, don't hesitate to contact us: manager@vph-institute.org

If you haven't had the chance to attend the webinar, the video recording is available for you to view on YouTube.

WATCH THE VIDEO

http://www.vph-institute.org/video/vphi-webinar-avicenna-alliance-vphi-2016-plan-and-working-groups.html

Gallery:

Watch the video
Date: 04/04/2016 | Tag: | News: 462 of 1626
All news

News

  • 05/11/2024

    "In silico trials: an updated SWOT Analysis" released by In Silico World

    • The document comprehensively examines the strengths, weaknesses, opportunities, and threats for In Silico Trials in healthcare, providing a roadmap to help biomedical companies navigate and adopt these innovative methodologies. -Read more-
  • 31/10/2024

    In the literature: October 2024 highlights

    • Click here to read some interesting recently published papers from our community. If you have published an article in the field of in silico medicine, send it to us: we will include it in this section of the newsletter! -Read more-
  • 31/10/2024

    Joint motion for a resolution to revise the Medical Devices Regulation

    • The European Parliament has voted with a large majority to urge the European Commission to implement critical amendments to the EU Medical Device Regulation (MDR) by the first quarter of 2025. The drive for reform is intended to tackle pressing issues in the regulation, which has been criticised for its excessive bureaucracy and impact on patient care, jobs, and innovation in the medical device sector. -Read more-
  • 31/10/2024

    EU Budget for 2025 Prioritizes Research, Health, Education, and Climate Action

    • The European Parliament has presented their draft budget demanding an EU budget for 2025 that focuses on improving people's lives, boosting competitiveness, and addressing current challenges. MEPs are proposing a budget of nearly €201 billion, which exceeds the European Commission's initial proposal of around €199.76 billion. -Read more-
More news

Events

More events
newsletter

Subscribe to the VPH Institute Newsletter

ARCHIVE

Read all the newsletters of the VPH Institute

GO